Structural analysis of neprilysin with various specific and potent inhibitors.

Article Details

Citation

Oefner C, Roques BP, Fournie-Zaluski MC, Dale GE

Structural analysis of neprilysin with various specific and potent inhibitors.

Acta Crystallogr D Biol Crystallogr. 2004 Feb;60(Pt 2):392-6. Epub 2004 Jan 23.

PubMed ID
14747736 [ View in PubMed
]
Abstract

Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a number of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor. Owing to the physiological importance of NEP in the modulation of nociceptive and pressor responses, there is considerable interest in inhibitors of this enzyme as novel analgesics and antihypertensive agents. Here, the crystal structures of the soluble extracellular domain of human NEP (residues 52-749) complexed with various potent and competitive inhibitors are described. The structures unambiguously reveal the binding mode of the different zinc-chelating groups and the subsite specificity of the enzyme.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
NeprilysinP08473Details